AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. PHR
  4. [Form 4] Phreesia, Inc. Insider Trading Activity

[Form 4] Phreesia, Inc. Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Amy VanDuyn, SVP Human Resources of Phreesia, Inc. (PHR), reported a sale of common stock executed on 08/25/2025 under a pre-existing Rule 10b5-1 trading plan adopted January 10, 2025. The report shows 18,573 shares were disposed of at a weighted-average price of $30.3696 per share (sales occurred at prices ranging from $30.00 to $30.81). After the reported transactions, the filing indicates the reporting person beneficially owned 110,607 shares, held directly.

Amy VanDuyn, SVP Risorse Umane di Phreesia, Inc. (PHR), ha comunicato la vendita di azioni ordinarie eseguita il 08/25/2025 nell'ambito di un piano di negoziazione Rule 10b5-1 preesistente adottato il 10 gennaio 2025. Il rapporto indica che sono state disposte 18.573 azioni a un prezzo medio ponderato di $30,3696 per azione (le vendite sono avvenute a prezzi compresi tra $30,00 e $30,81). Dopo le transazioni riportate, la documentazione segnala che la persona che ha effettuato la segnalazione deteneva direttamente 110.607 azioni come beneficiario effettivo.

Amy VanDuyn, SVP de Recursos Humanos de Phreesia, Inc. (PHR), inform贸 la venta de acciones comunes ejecutada el 08/25/2025 bajo un plan de negociaci贸n Rule 10b5-1 preexistente adoptado el 10 de enero de 2025. El informe muestra que se dispusieron 18.573 acciones a un precio promedio ponderado de $30.3696 por acci贸n (las ventas se realizaron a precios que oscilaban entre $30.00 y $30.81). Tras las transacciones reportadas, la presentaci贸n indica que la persona informante pose铆a beneficiosamente 110.607 acciones, en propiedad directa.

Phreesia, Inc.(PHR)鞚� 鞚胳偓雼措嫻 靾橃劃攵�靷灔(Amy VanDuyn)鞚� 2025雲� 1鞗� 10鞚� 毂勴儩霅� 旮办〈鞚� Rule 10b5-1 瓯半灅瓿勴殟鞐� 霐半澕 2025-08-25鞐� 氤错喌欤茧ゼ 毵る弰頄堧嫟瓿� 氤搓碃頄堨姷雼堧嫟. 氤搓碃靹滌棎 霐半ゴ氅� 齑� 18,573欤缄皜 欤茧嫻 臧�欷戫弶攴� $30.3696鞐� 觳橂秳霅橃棃鞙茧┌(毵り皝 臧�瓴� 氩旍渼: $30.00~$30.81), 氤搓碃霅� 瓯半灅 頉� 頃措嫻 氤搓碃鞚胳潃 歆侅爲 靻岇湢頃� 110,607欤茧ゼ 靷嫟靸� 氤挫湢頃橁碃 鞛堧姅 瓴冹溂搿� 響滌嫓霅橃棃鞀惦媹雼�.

Amy VanDuyn, SVP des ressources humaines de Phreesia, Inc. (PHR), a d茅clar茅 une vente d'actions ordinaires r茅alis茅e le 25/08/2025 dans le cadre d'un plan de n茅gociation Rule 10b5-1 pr茅existant adopt茅 le 10 janvier 2025. Le rapport indique que 18 573 actions ont 茅t茅 c茅d茅es 脿 un prix moyen pond茅r茅 de 30,3696 $ par action (les ventes se sont d茅roul茅es 脿 des prix compris entre 30,00 $ et 30,81 $). Apr猫s les transactions signal茅es, le dossier pr茅cise que la personne ayant fait la d茅claration d茅tenait directement 110 607 actions 脿 titre b茅n茅ficiaire effectif.

Amy VanDuyn, SVP Human Resources von Phreesia, Inc. (PHR), meldete den Verkauf von Stammaktien, ausgef眉hrt am 25.08.2025, im Rahmen eines bereits bestehenden Rule-10b5-1-Handelsplans, der am 10. Januar 2025 angenommen wurde. Der Bericht zeigt, dass 18.573 Aktien zu einem gewogenen Durchschnittspreis von $30,3696 pro Aktie ver盲u脽ert wurden (Verk盲ufe erfolgten zu Preisen zwischen $30,00 und $30,81). Nach den gemeldeten Transaktionen gibt die Einreichung an, dass die meldende Person wirtschaftlich 110.607 Aktien direkt hielt.

Positive
  • Sale executed under a Rule 10b5-1 trading plan, indicating pre-arranged, compliant trading
  • Price range disclosed ($30.00 to $30.81) and weighted-average price provided ($30.3696), supporting transparency
  • Reporting of beneficial ownership after transaction (110,607 shares) clarifies remaining insider stake
Negative
  • Reporting person disposed of 18,573 shares, reducing insider ownership
  • Filing does not disclose per-trade breakdown without request (only a weighted average and range are provided)

Insights

TL;DR: Insider executed a planned sale under a 10b5-1 plan; transaction appears routine and provides liquidity.

The sale of 18,573 shares at a weighted-average price of $30.3696 was effected pursuant to a Rule 10b5-1 plan adopted on January 10, 2025, which indicates pre-arranged trading rather than an opportunistic market-timing decision. The filing shows 110,607 shares remained beneficially owned following the sales. From an analytic perspective, this is a compliance-driven disposition that provides clarity on timing and price range ($30.00鈥�$30.81) for the trades.

TL;DR: Use of a documented 10b5-1 plan demonstrates adherence to insider-trading controls and disclosure obligations.

The reporting indicates the transaction was executed under a written 10b5-1 plan, which typically mitigates regulatory risk by establishing an affirmative defense. The filer disclosed the weighted-average sale price and the price range and committed to provide detailed per-price breakdowns on request, reflecting transparency. The report was signed by an authorized attorney-in-fact on behalf of the reporting person, consistent with filing procedures.

Amy VanDuyn, SVP Risorse Umane di Phreesia, Inc. (PHR), ha comunicato la vendita di azioni ordinarie eseguita il 08/25/2025 nell'ambito di un piano di negoziazione Rule 10b5-1 preesistente adottato il 10 gennaio 2025. Il rapporto indica che sono state disposte 18.573 azioni a un prezzo medio ponderato di $30,3696 per azione (le vendite sono avvenute a prezzi compresi tra $30,00 e $30,81). Dopo le transazioni riportate, la documentazione segnala che la persona che ha effettuato la segnalazione deteneva direttamente 110.607 azioni come beneficiario effettivo.

Amy VanDuyn, SVP de Recursos Humanos de Phreesia, Inc. (PHR), inform贸 la venta de acciones comunes ejecutada el 08/25/2025 bajo un plan de negociaci贸n Rule 10b5-1 preexistente adoptado el 10 de enero de 2025. El informe muestra que se dispusieron 18.573 acciones a un precio promedio ponderado de $30.3696 por acci贸n (las ventas se realizaron a precios que oscilaban entre $30.00 y $30.81). Tras las transacciones reportadas, la presentaci贸n indica que la persona informante pose铆a beneficiosamente 110.607 acciones, en propiedad directa.

Phreesia, Inc.(PHR)鞚� 鞚胳偓雼措嫻 靾橃劃攵�靷灔(Amy VanDuyn)鞚� 2025雲� 1鞗� 10鞚� 毂勴儩霅� 旮办〈鞚� Rule 10b5-1 瓯半灅瓿勴殟鞐� 霐半澕 2025-08-25鞐� 氤错喌欤茧ゼ 毵る弰頄堧嫟瓿� 氤搓碃頄堨姷雼堧嫟. 氤搓碃靹滌棎 霐半ゴ氅� 齑� 18,573欤缄皜 欤茧嫻 臧�欷戫弶攴� $30.3696鞐� 觳橂秳霅橃棃鞙茧┌(毵り皝 臧�瓴� 氩旍渼: $30.00~$30.81), 氤搓碃霅� 瓯半灅 頉� 頃措嫻 氤搓碃鞚胳潃 歆侅爲 靻岇湢頃� 110,607欤茧ゼ 靷嫟靸� 氤挫湢頃橁碃 鞛堧姅 瓴冹溂搿� 響滌嫓霅橃棃鞀惦媹雼�.

Amy VanDuyn, SVP des ressources humaines de Phreesia, Inc. (PHR), a d茅clar茅 une vente d'actions ordinaires r茅alis茅e le 25/08/2025 dans le cadre d'un plan de n茅gociation Rule 10b5-1 pr茅existant adopt茅 le 10 janvier 2025. Le rapport indique que 18 573 actions ont 茅t茅 c茅d茅es 脿 un prix moyen pond茅r茅 de 30,3696 $ par action (les ventes se sont d茅roul茅es 脿 des prix compris entre 30,00 $ et 30,81 $). Apr猫s les transactions signal茅es, le dossier pr茅cise que la personne ayant fait la d茅claration d茅tenait directement 110 607 actions 脿 titre b茅n茅ficiaire effectif.

Amy VanDuyn, SVP Human Resources von Phreesia, Inc. (PHR), meldete den Verkauf von Stammaktien, ausgef眉hrt am 25.08.2025, im Rahmen eines bereits bestehenden Rule-10b5-1-Handelsplans, der am 10. Januar 2025 angenommen wurde. Der Bericht zeigt, dass 18.573 Aktien zu einem gewogenen Durchschnittspreis von $30,3696 pro Aktie ver盲u脽ert wurden (Verk盲ufe erfolgten zu Preisen zwischen $30,00 und $30,81). Nach den gemeldeten Transaktionen gibt die Einreichung an, dass die meldende Person wirtschaftlich 110.607 Aktien direkt hielt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
VanDuyn Amy Beth
(Last) (First) (Middle)
C/O PHREESIA, INC.
1521 CONCORD PIKE, SUITE 301 PMB 221
(Street)
WILMINGTON DE 19803
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Phreesia, Inc. [ PHR ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP, Human Resources
3. Date of Earliest Transaction (Month/Day/Year)
08/25/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/25/2025 S(1) 18,573 D $30.3696(2) 110,607 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 10, 2025.
2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.81 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Allison Hoffman by Power of Attorney for Amy VanDuyn 08/27/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

What did Amy VanDuyn (PHR) report on Form 4?

She reported the sale of 18,573 shares of Phreesia common stock executed on 08/25/2025 under a Rule 10b5-1 plan.

At what price were the PHR shares sold?

The weighted-average price was $30.3696 and the individual sale prices ranged from $30.00 to $30.81 per share.

How many PHR shares did the reporting person own after the sale?

110,607 shares were reported as beneficially owned following the transactions.

Was the sale part of a 10b5-1 plan for PHR insider trading?

Yes. The Form 4 states the transactions were effected pursuant to a Rule 10b5-1 trading plan adopted January 10, 2025.

Who filed the Form 4 for Amy VanDuyn (PHR)?

The form was signed by an attorney-in-fact on behalf of the reporting person as indicated in the filing.
Stock PHR logo
Phreesia

NYSE:PHR

PHR Rankings

#2139 Ranked by Market Cap
N/A Ranked by Dividends

PHR Latest News

Sep 4, 2025
Phreesia Announces Second Quarter Fiscal 2026 Results
Sep 4, 2025
Phreesia to Acquire AccessOne, Expanding Its Suite of Payment Solutions
Sep 2, 2025
Phreesia Launches VoiceAI, a Conversational AI Solution to Transform Call Management in Healthcare
Aug 21, 2025
Phreesia and Sesame Workshop Announce 5-Year Collaboration to Improve the Health of Millions of Children Through the Power of Sesame Street
Aug 12, 2025
Phreesia Named to the 2025 Capterra Shortlist for Patient Engagement and Medical Scheduling

PHR Latest SEC Filings

Sep 5, 2025
[10-Q] Phreesia, Inc. Quarterly Earnings Report
Sep 4, 2025
[8-K] Phreesia, Inc. Reports Material Event
Aug 29, 2025
[Form 4] Phreesia, Inc. Insider Trading Activity
Aug 29, 2025
[Form 4] Phreesia, Inc. Insider Trading Activity
Aug 28, 2025
[144] Phreesia, Inc. SEC Filing

PHR Stock Data

1.86B
56.77M
4.33%
100.74%
4.88%
Health Information Services
Services-business Services, Nec
United States
WILMINGTON